V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011329 | 330003786 | 1.64 | 31 | Adjuvant (A) | 2015-03-05 | 2015-03-22 | Cisplatin 7 day | 2 | N | 330007346 | CISPLATIN |
| 330011330 | 330003789 | 1.65 | 61 | Curative (C) | 2015-09-04 | 2016-03-09 | OST Euramos 1 Closed Trial - A | 02 | N | 330007347 | DOXORUBICIN |
| 330011331 | 330003791 | 1.6 | null | Curative (C) | 2015-05-11 | 2016-02-16 | DOXORUBICIN | N | N | 330007358 | DOXORUBICIN |
| 330011332 | 330008048 | 1.57 | 125.6 | Neo-adjuvant (N) | 2014-06-05 | 2014-06-16 | Mifamurtide weeks 1-12 | N | Y | 330007358 | MIFAMURTIDE |
| 330011333 | 330012767 | 1.61 | 59.3 | Curative (C) | 2015-05-18 | 2015-07-24 | Cisplatin 7 day | Y | N | 330007365 | CISPLATIN |
| 330011334 | 330010366 | 0 | 53.2 | Curative (C) | 2016-08-05 | 2016-12-06 | EW EuroEwing 2012 Arm B IE | 02 | N | 330007368 | TRIAL |
| 330011335 | 330003796 | 1.71 | 47 | Adjuvant (A) | 2018-06-09 | 2018-06-12 | MIFAMURTIDE | 02 | N | 330007378 | MIFAMURTIDE |
| 330011336 | 330008052 | 1.59 | 56 | null | 2015-10-12 | 2016-03-14 | DOXORUBICIN | N | N | 330007381 | DOXORUBICIN |
| 330011337 | 330008055 | null | null | Curative (C) | 2015-11-06 | 2015-11-20 | Trial Unspecified | N | N | 330007390 | TRIAL |
| 330011338 | 330003803 | 1.62 | 58 | Curative (C) | 2016-04-06 | 2016-09-06 | Trial Unspecified | 02 | N | 330007399 | TRIAL |
| 330011339 | 330003806 | 1.79 | 61.6 | Neo-adjuvant (N) | 2018-01-23 | 2018-02-06 | Trial Unspecified | N | N | 330007412 | TRIAL |
| 330011340 | 330003808 | 0 | 54.8 | Adjuvant (A) | 2012-09-20 | 2013-07-31 | DOXORUBICIN | N | N | 330007417 | DOXORUBICIN |
| 330011341 | 330008058 | null | null | Palliative (P) | null | 2014-08-29 | METHOTREXATE | N | null | 330007427 | METHOTREXATE |
| 330011342 | 330003811 | 1.62 | 66.8 | Curative (C) | 2016-01-20 | 2016-02-15 | Cisplatin 7 day | N | Y | 330007437 | CISPLATIN |
| 330011344 | 330003812 | 1.71 | null | Adjuvant (A) | 2016-10-09 | 2016-11-06 | MIFAMURTIDE | 01 | N | 330007452 | MIFAMURTIDE |
| 330011345 | 330003817 | 0 | null | Neo-adjuvant (N) | 2016-05-09 | 2016-05-16 | EW EuroEwing 2012 Arm B IE | 1 | N | 330007467 | TRIAL |
| 330011346 | 330003819 | 1.72 | 51 | Neo-adjuvant (N) | 2015-01-14 | 2015-02-05 | Trial Unspecified | N | N | 330007476 | TRIAL |
| 330011347 | 330003821 | 0 | 74.3 | Neo-adjuvant (N) | null | 2015-05-16 | METHOTREXATE | 02 | N | 330007479 | METHOTREXATE |
| 330011348 | 330003824 | 1.58 | 99.5 | null | null | 2015-04-26 | MIFAMURTIDE | N | null | 330007485 | MIFAMURTIDE |
| 330011349 | 330003827 | 1.63 | 39.8 | Neo-adjuvant (N) | 2013-12-04 | 2014-02-20 | EW EuroEwing 2012 Arm B IE | N | null | 330007486 | TRIAL |
| 330011350 | 330010379 | 1.04 | null | Curative (C) | 2018-03-02 | 2018-05-02 | Cisplatin | Y | N | 330007490 | CISPLATIN |
| 330011351 | 330003829 | 0 | null | Curative (C) | 2013-07-31 | 2013-12-14 | Mifamurtide weeks 13-36 | N | N | 330007491 | MIFAMURTIDE |
| 330011352 | 330003830 | 1.73 | 133 | Palliative (P) | 2017-01-16 | 2017-02-24 | OST Euramos 1 Closed Trial - IE | N | N | 330007503 | TRIAL |
| 330011353 | 330003834 | 1.77 | 65.1 | Curative (C) | null | 2016-06-15 | DOXORUBICIN | null | null | 330007519 | DOXORUBICIN |
| 330011355 | 330003838 | 1.77 | null | Neo-adjuvant (N) | null | 2015-11-15 | MIFAMURTIDE | Y | null | 330007540 | MIFAMURTIDE |
| 330011356 | 330003841 | 0 | 49.6 | Curative (C) | 2014-07-27 | 2014-08-07 | METHOTREXATE | Y | Y | 330007542 | METHOTREXATE |
| 330011357 | 330008082 | 1.89 | 83 | Adjuvant (A) | 2014-07-02 | 2015-02-06 | MIFAMURTIDE | Y | N | 330007561 | MIFAMURTIDE |
| 330011358 | 330003849 | 1.8 | 49.6 | Curative (C) | 2017-12-02 | 2017-12-02 | Cisplatin | 02 | N | 330007563 | CISPLATIN |
| 330011359 | 330003850 | 1.7 | null | null | 2014-02-07 | 2014-08-07 | OST Mifamurtide | N | N | 330007570 | MIFAMURTIDE |
| 330011360 | 330003852 | 1.74 | 82.25 | null | 2017-12-11 | 2017-12-11 | DOXORUBICIN | N | N | 330007579 | DOXORUBICIN |
| 330011361 | 330003857 | 1.65 | 56 | Palliative (P) | 2012-06-19 | 2012-10-23 | Doxorubicin 75mg/m2 | N | N | 330007587 | DOXORUBICIN |
| 330011362 | 330008092 | 1.75 | 17.4 | Curative (C) | 2018-01-01 | 2018-01-06 | Trial Unspecified | 02 | N | 330007601 | TRIAL |
| 330011365 | 330010389 | 0 | 54.7 | Palliative (P) | 2016-08-06 | 2016-08-06 | GALAXY 2 TRIAL | N | N | 330007616 | TRIAL |
| 330011366 | 330008098 | 1.81 | null | Disease modification (D) | 2015-07-28 | 2015-07-30 | METHOTREXATE | N | N | 330007623 | METHOTREXATE |
| 330011367 | 330008099 | 1.65 | 33.5 | Not known (9) | 2016-08-18 | 2016-08-21 | Cisplatin | 1 | N | 330007628 | CISPLATIN |
| 330011368 | 330003878 | 1.74 | 68 | Adjuvant (A) | 2018-02-14 | 2018-03-07 | OST Euramos 1 Closed Trial - A | 02 | N | 330007660 | DOXORUBICIN |
| 330011369 | 330003884 | 0 | 66.8 | Curative (C) | 2014-11-02 | 2014-11-26 | METHOTREXATE | N | N | 330007672 | METHOTREXATE |
| 330011370 | 330008106 | 1.83 | 92 | Curative (C) | 2015-06-23 | 2015-09-25 | MIFAMURTIDE | Y | N | 330007676 | MIFAMURTIDE |
| 330011371 | 330003886 | null | 66.8 | Disease modification (D) | 2017-12-15 | 2018-06-03 | Trial Unspecified | null | null | 330007676 | TRIAL |
| 330011372 | 330003887 | 1.61 | 42.3 | Palliative (P) | 2017-01-03 | 2017-04-08 | EW EuroEwing 2012 Arm A VAI | 2 | N | 330007685 | TRIAL |
| 330011373 | 330003889 | 1.88 | 32.5 | Adjuvant (A) | 2015-03-15 | 2015-03-16 | Trial Unspecified | N | N | 330007703 | TRIAL |
| 330011374 | 330008112 | null | 74.65 | Neo-adjuvant (N) | 2013-02-27 | 2013-04-09 | Methotrexate Intermed dose (1g/m2) | Y | null | 330007719 | METHOTREXATE |
| 330011375 | 330003894 | null | 55.8 | Neo-adjuvant (N) | null | 2016-06-20 | Cisplatin | null | null | 330007724 | CISPLATIN |
| 330011376 | 330003904 | 1.79 | 50.3 | Neo-adjuvant (N) | null | 2017-08-14 | DOXORUBICIN | N | null | 330007730 | DOXORUBICIN |
| 330011377 | 330003906 | 1.8 | 77.9 | Curative (C) | null | 2016-02-17 | MIFAMURTIDE | N | null | 330007739 | MIFAMURTIDE |
| 330011378 | 330003907 | 1.93 | 92 | Curative (C) | 2015-07-03 | 2015-07-05 | Cisplatin | 01 | N | 330007750 | CISPLATIN |
| 330011379 | 330003909 | 1.75 | 59.2 | Curative (C) | 2016-12-31 | 2016-12-31 | Mifamurtide weeks 1-12 | N | N | 330007754 | MIFAMURTIDE |
| 330011380 | 330003912 | null | 46.4 | Neo-adjuvant (N) | 2017-06-18 | 2018-02-28 | Mifamurtide weeks 1-12 | null | null | 330007774 | MIFAMURTIDE |
| 330011381 | 330008121 | 0 | 55.8 | null | 2015-07-07 | 2015-07-07 | Doxorubicin 75mg/m2 | N | N | 330007776 | DOXORUBICIN |
| 330011382 | 330010407 | 1.75 | null | Neo-adjuvant (N) | 2013-10-05 | 2013-10-05 | Trial Unspecified | null | null | 330007780 | TRIAL |